Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
05/1998
05/28/1998WO1998022585A1 HUMAN POLYHOMEOTIC 2(hph2) ACTS AS AN ONCOGENE
05/28/1998WO1998022584A1 C1q RECEPTOR, ENCODING GENE AND APPLICATION IN HOST DEFENSE ENHANCEMENT
05/28/1998WO1998022581A1 Transcription repressor
05/28/1998WO1998022579A1 Insulin-like growth factor 1 receptor (igf-1r) antisense oligonucleotide-treated breast cancer cells composition
05/28/1998WO1998022507A2 Receptor tyrosine kinase genes
05/28/1998WO1998022506A1 Human kdel receptor
05/28/1998WO1998022501A2 Secreted proteins and polynucleotides encoding them
05/28/1998WO1998022497A1 Preprotachykinin-c gene encoding substance z tachykinin precursor
05/28/1998WO1998022492A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon
05/28/1998WO1998022145A1 Immunization of infants
05/28/1998WO1998022144A2 Complexes of adenovirus with cationic molecules
05/28/1998WO1998022143A1 Chimeric retrovirus/adenovirus system
05/28/1998WO1998022142A1 Antisense oligonucleotide compositions for selectively killing cancer cells
05/28/1998WO1998022140A2 Hybrid compositions for intracellular targeting
05/28/1998WO1998022133A1 NOVEL FabD
05/28/1998WO1998022128A1 Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
05/28/1998WO1998022127A1 Pretreatment with growth factors to protect against cns damage
05/28/1998WO1998012328A3 Human bad polypeptides, encoding nucleic acids and methods of use
05/28/1998WO1998002191A3 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules
05/28/1998CA2275438A1 Improved methods for transducing cells
05/28/1998CA2272824A1 Insulin-like growth factor 1 receptor (igf-1r) antisense oligonucleotide-treated breast cancer cells composition
05/28/1998CA2272747A1 Hybrid compositions for intracellular targeting
05/28/1998CA2272744A1 Chimeric adenoviral vectors
05/28/1998CA2272578A1 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth
05/28/1998CA2272545A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon
05/28/1998CA2272341A1 Antisense oligonucleotide compositions for selectively killing cancer cells
05/28/1998CA2272121A1 Chimeric retrovirus/adenovirus system
05/28/1998CA2272050A1 Secreted proteins and polynucleotides encoding them
05/28/1998CA2271950A1 Receptor tyrosine kinase genes
05/28/1998CA2271783A1 Survivin, a protein that inhibits cellular apoptosis, and its modulation
05/28/1998CA2271714A1 Preprotachykinin-c gene encoding substance z tachykinin precursor
05/28/1998CA2271437A1 Recombinant bicistron adenovirus for treating pathological conditions linked with dyslipoproteinemia
05/28/1998CA2270407A1 Human kdel receptor
05/28/1998CA2267833A1 Novel polymeric complexes for the transfection of nucleic acids, with residues causing the destabilisation of cell membranes
05/28/1998CA2266659A1 Pretreatment with growth factors to protect against cns damage
05/27/1998EP0844307A1 Candida albicans protein caYAE1
05/27/1998EP0844305A2 hRAD54
05/27/1998EP0844004A1 Gene preparations
05/27/1998EP0843732A1 Natural or synthetic retroelement sequence enabling nucleotide sequence insertion into a eukaryotic cell
05/27/1998EP0843731A1 Adenovirus vectors for gene therapy
05/27/1998EP0843555A1 Liposomal oligonucleotide compositions
05/27/1998CA2216625A1 Novel compounds
05/26/1998US5756668 Hypermethylated in cancer polypeptide, HIC-1
05/26/1998US5756455 Amplification of human MDM2 gene in human tumors
05/26/1998US5756353 Introducing dna into cell of proximal or distal airways of a mammal by administering aerosol lipid-dna complex
05/26/1998US5756329 DNA encoding phenylalanyl tRNA synthetase from Staphylococcus aureus
05/26/1998US5756310 Culture product
05/26/1998US5756309 Nucleic acid encoding a human G-protein receptor HPRAJ70 and method of producing the receptor
05/26/1998US5756283 Transduction, genetic engineering, gene expression; cancer treatment
05/26/1998US5756264 Expression vector systems and method of use
05/26/1998US5756086 Gene expression; anticarcinogenic agents
05/25/1998CA2216622A1 Novel compounds
05/25/1998CA2215929A1 Novel lep
05/22/1998WO1998021364A2 Method and apparatus for preparing sample cartridges for a particle acceleration device
05/22/1998WO1998021363A1 Compositions and methods for treating type ii diabetes involving hnf-4
05/22/1998WO1998021359A1 Glutathione s-transferase (gst) genes in cancer
05/22/1998WO1998021354A1 Poxvirus-based expression vectors containing heterologous inserts derived from lentiviruses
05/22/1998WO1998021350A1 Diminishing viral gene expression by promoter replacement
05/22/1998WO1998021349A1 Novel constructs and vectors for the targeted and inducible expression of genes
05/22/1998WO1998021345A1 Hsv/aav hybrid amplicon vectors
05/22/1998WO1998021343A1 Genes encoding telomerase proteins
05/22/1998WO1998021334A2 Antibody mg1 recognizing a small subset of human hematopoietic cells
05/22/1998WO1998021333A2 Nucleic acid encoding schwannomin-binding-proteins and products related thereto
05/22/1998WO1998021331A1 Human breast tumor-specific proteins
05/22/1998WO1998021324A1 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof
05/22/1998WO1998021322A1 Design principle for constructing expression constructs for gene therapy
05/22/1998WO1998021228A1 Tissue specific expression of retinoblastoma protein
05/22/1998WO1998020907A1 TGFβ1-RESPONSIVE CELLS FROM BONE MARROW
05/22/1998WO1998020906A2 Treatment of diabetes with transcription factor gene
05/22/1998WO1998020897A1 Modulation of map kinase phosphatase 1 (mkp-1)
05/22/1998WO1998020857A1 Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery
05/22/1998WO1998011244A3 AAV4 vector and uses thereof
05/22/1998WO1998010795A3 Tumor homing molecules, conjugates derived therefrom, and methods of using same
05/22/1998CA2271951A1 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof
05/22/1998CA2271777A1 Hsv/aav hybrid amplicon vectors
05/22/1998CA2271734A1 Tgf.beta.1-responsive cells from bone marrow
05/22/1998CA2271718A1 Genes encoding telomerase proteins
05/22/1998CA2271325A1 Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery
05/22/1998CA2271100A1 Treatment of diabetes with transcription factor gene
05/22/1998CA2270910A1 Glutathione s-transferase (gst) genes in cancer
05/22/1998CA2270875A1 Nucleic acid encoding schwannomin-binding-proteins and products related thereto
05/22/1998CA2270156A1 Human breast tumor-specific proteins
05/22/1998CA2269864A1 Novel constructs and vectors for the targeted and inducible expression of genes
05/21/1998CA2216616A1 Cayae1
05/20/1998EP0843016A2 Staphylococcus FabD (malonylCoA:ACP transacylase) protein
05/20/1998EP0843014A2 Tryptophanyl tRNA synthetase
05/20/1998EP0843011A2 RsbU-1 derived from Staphylococcus
05/20/1998EP0843009A2 A human mytrophin clone hsabh01
05/20/1998EP0842665A2 Interleukin-1 beta converting enzyme like apoptotic proteases and their agonists
05/20/1998EP0842288A1 Improvements in or relating to delivery of nucleic acid
05/20/1998EP0842280A2 Mammalian pro-hormone convertase
05/20/1998EP0842279A2 Helper viruses for preparing recombinant viral vectors
05/20/1998EP0842277A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis
05/20/1998EP0842270A1 Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
05/20/1998EP0842267A1 Mch2, AN APOPTOTIC CYSTEINE PROTEASE, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME
05/20/1998EP0842266A1 Transgenic swine and swine cells having human hla genes
05/20/1998EP0842209A2 Multiblock biodegradable hydrogels for use as controlled release agents for drugs and tissue treatment agents
05/20/1998EP0842189A1 Early onset alzheimer's disease gene and gene products
05/20/1998EP0842186A1 Cross-linking oligonucleotides
05/20/1998EP0841950A1 Neuronal progenitor cells and uses thereof
1 ... 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 ... 870